rs397516748
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_002294.3(LAMP2):c.842A>G(p.Tyr281Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000915 in 1,093,450 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002294.3 missense
Scores
Clinical Significance
Conservation
Publications
- Danon diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LAMP2 | NM_002294.3 | c.842A>G | p.Tyr281Cys | missense_variant | Exon 6 of 9 | ENST00000200639.9 | NP_002285.1 | |
| LAMP2 | NM_001122606.1 | c.842A>G | p.Tyr281Cys | missense_variant | Exon 6 of 9 | NP_001116078.1 | ||
| LAMP2 | NM_013995.2 | c.842A>G | p.Tyr281Cys | missense_variant | Exon 6 of 9 | NP_054701.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome AF: 9.15e-7 AC: 1AN: 1093450Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 358954 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Tyr281Cys varia nt (LAMP2) has not been previously reported. It has been detected by our labora tory in 1 out of >1250 Caucasian probands tested. This individual had DCM + mus cle weakness and carried a likely pathogenic variant in the LMNA gene. A reporte d paternal family history of disease is be inconsistent with X-linked inheritanc e and argues against a pathogenic role of the Tyr281Cys variant. In addition, ty rosine (Tyr) at position 281 is not conserved in mammals and lower species, sugg esting that a change at this position may be tolerated. Computational prediction s are mixed on the predicted impact to the protein (AlignGVGD = benign and SIFT = pathogenic), though the accuracy of these tools is unknown. Importantly, path ogenic missense variants are very rare in the LAMP2 gene (most disease causing v ariants cause a loss of function). In summary, this variant is less likely disea se causing and is more likely a modifier or benign. However, additional evidenc e is needed to determine this with certainty. -
Danon disease Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LAMP2 protein function. ClinVar contains an entry for this variant (Variation ID: 44439). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 27532257). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 281 of the LAMP2 protein (p.Tyr281Cys). -
Cardiovascular phenotype Uncertain:1
The c.842A>G (p.Y281C) alteration is located in exon 6 (coding exon 6) of the LAMP2 gene. This alteration results from a A to G substitution at nucleotide position 842, causing the tyrosine (Y) at amino acid position 281 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at